Dr. Jill Shukla is a distinguished pharmaceutical scientist, researcher, entrepreneur, and healthcare innovator with a vision to transform scientific research into impactful healthcare solutions. As the Founder & Director of Volonium, she leads a research-driven pharmaceutical and nutraceutical organization with manufacturing operations in Bardoli, Gujarat, India, and research & development activities in Edison, New Jersey, USA.
Holding a Doctorate in
Pharmaceutics, Dr. Shukla possesses multidisciplinary expertise spanning
Pharmaceutical Research & Development, Regulatory Affairs, Good
Manufacturing Practices (GMP), Nutraceutical Innovation, and Patents &
Intellectual Property. Dr. Shukla’s contributions to pharmaceutical sciences
and healthcare innovation have earned her national and international
recognition.
Her inclusion in the globally respected Marquis Who’s Who – 125th
Edition further highlights her growing impact in pharmaceutical
sciences, healthcare innovation, and research leadership on an international
platform.
She was honoured with the prestigious “Women of Excellence” National Award 2025 by the All India Business and Community Foundation, India, in recognition of her exemplary leadership, scientific contribution, and professional excellence.
During the pandemic period, Dr. Shukla’s insights on the evolving landscape of pharmaceutical research and development were featured in an exclusive interview by CPHI. She was also recognized among the “20 Most Reputed Business Leaders in the Pharmaceutical and Life Sciences Industry – 2022” by The CEO Magazine.
An accomplished author, researcher, and academic contributor, Dr. Shukla has significantly contributed to scientific literature through multiple books, book chapters, and peer-reviewed research publications.
Driven by a passion to bridge the gap between laboratory innovation and patient-centered healthcare, Dr. Jill Shukla transformed her academic vision into a purpose-led enterprise through Volonium. Her mission is to create innovative, science-driven, and sustainable healthcare solutions that positively impact lives globally.
“The New Innings of Success Through Innovation in Healthcare”